Azenta announces agreement to acquire B Medical Systems

Azenta, Inc. today announced that it has entered into a definitive agreement to acquire B Medical Systems S.á r.l and its subsidiaries (“B Medical”), a market leader in temperature-controlled storage and transportation solutions that enables the delivery of life-saving treatments across the globe. The cash purchase price to be paid at closing will be approximately €410 million. Additional cash consideration, up to €50 million, may be paid upon achievement of certain future performance milestones. The transaction is expected to close in October 2022.

Azenta announces agreement to acquire B Medical Systems

Image Credit: B Medical Systems

B Medical is headquartered in Hosingen, Luxembourg and is one of the leading vaccine cold chain providers serving primarily fast-growing emerging markets, which require secure and reliable temperature-controlled storage and transport solutions. The portfolio includes vaccine transport systems with real-time monitoring solutions, medical refrigeration for ambient to -86 °C temperatures, and blood management solutions. B Medical has an installed base of more than 500,000 units spanning approximately 150 countries across the globe. The Luxembourg headquarters includes a state-of-the-art, highly automated manufacturing facility.

This acquisition complements Azenta’s cold chain capabilities, adding differentiated solutions for reliable and traceable transport of temperature-sensitive specimens.

We are excited to add B Medical into our growing portfolio of offerings. B Medical has done an outstanding job carving out a strong market position in the vaccine cold chain, and we see a breadth of opportunities to drive even further value from the portfolio by leveraging the Azenta platform.”

Steve Schwartz, President and CEO, Azenta.

B Medical CEO, Luc Provost, who has been with the company for over 20 years, and Jesal Doshi, Deputy CEO since 2015, are expected to join Azenta and continue to lead the business.

We are excited to join the Azenta team as we combine our capabilities and expertise in cold chain solutions to drive the next leg of growth. Together, I look forward to continuing our mission to create technology that helps save lives across the world.”

Mr. Luc Provost, CEO, B Medical Systems

Click here to read the full press release from Azenta

Click here to read the press release from Navis Capital Partners

Citations

Please use one of the following formats to cite this article in your essay, paper or report:

  • APA

    B Medical Systems S.à r.l. (2024, September 20). Azenta announces agreement to acquire B Medical Systems. News-Medical. Retrieved on December 10, 2024 from https://www.news-medical.net/news/20220816/Azenta-announces-agreement-to-acquire-B-Medical-Systems.aspx.

  • MLA

    B Medical Systems S.à r.l. "Azenta announces agreement to acquire B Medical Systems". News-Medical. 10 December 2024. <https://www.news-medical.net/news/20220816/Azenta-announces-agreement-to-acquire-B-Medical-Systems.aspx>.

  • Chicago

    B Medical Systems S.à r.l. "Azenta announces agreement to acquire B Medical Systems". News-Medical. https://www.news-medical.net/news/20220816/Azenta-announces-agreement-to-acquire-B-Medical-Systems.aspx. (accessed December 10, 2024).

  • Harvard

    B Medical Systems S.à r.l. 2024. Azenta announces agreement to acquire B Medical Systems. News-Medical, viewed 10 December 2024, https://www.news-medical.net/news/20220816/Azenta-announces-agreement-to-acquire-B-Medical-Systems.aspx.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.